Blood News and Research

RSS

Tanaka develops world's first kit to directly detect ZIKA virus in blood

Tanaka Holdings Co., Ltd. announced today that Tanaka Kikinzoku Kogyo K.K., which operates the Tanaka Precious Metals manufacturing business, has developed the world's first kit able to directly detect the ZIKA virus in blood. The kit is capable of rapid ZIKV detection in just 10 to 15 minutes.

7 Jun 2016

Coagadex now available for rare bleeding disorder patients in the UK

Bio Products Laboratory, Limited (BPL) today announced that Coagadex is now available for patients in the UK.

7 Jun 2016

Existing immunotherapy drug pembrolizumab shows promise for specific sarcoma subtypes

An existing cancer immunotherapy drug reduces tumor size in some types of rare connective tissue cancers, called sarcomas, report researchers at the University of Pittsburgh Cancer Institute.

7 Jun 2016

Study may help identify genetic basis of why some people's brains age better than others

More than one thousand people have had their entire genetic make-up decoded as part of a long-term study to gain insight into why some people's brains age better than others.

7 Jun 2016

Disruptive sleep patterns could raise heart disease risk in shift workers and insomniacs

People who suffer from a lack of sleep and disordered sleep cycles could be increasing their chances of developing cardiovascular disease, according to a study in the American Heart Association’s Journal Hypertension.

7 Jun 2016

Study establishes copper’s role in fat metabolism

A new study is further burnishing copper's reputation as an essential nutrient for human physiology. A research team led by a scientist at the Department of Energy's Lawrence Berkeley National Laboratory and at the University of California, Berkeley, has found that copper plays a key role in metabolizing fat.

7 Jun 2016

Eculizumab drug provides new hope for kidney failure patients

Surgeons at the University of Illinois Hospital & Health Sciences System have — for the first time — used an orphan drug to prevent rejection of a kidney transplanted from a living donor with a mismatched blood type.

7 Jun 2016

Research shows weekend admissions in NHS hospital can affect AF patients

Patients suffering from the most common form of heart rhythm disorder who are admitted to NHS hospital over the weekend face a higher risk of dying over the next five years than those admitted during normal hours.

7 Jun 2016

Human stem cells restore motor function in chronic stroke patients

Injecting modified, human, adult stem cells directly into the brains of chronic stroke patients proved not only safe but effective in restoring motor function, according to the findings of a small clinical trial led by Stanford University School of Medicine investigators.

7 Jun 2016

Researchers establish new method to culture kidney progenitor cells for regenerative medicine

Research into kidney regeneration, an organ that has been extremely difficult to regenerate, has taken a great stride forward with research coming out of a collaboration between Kumamoto University, Japan and the National Cancer Institute of the US.

7 Jun 2016

Genes of healthy leanness could lead to new approach to treating obesity-related diabetes

People with type 2 diabetes could be helped by the discovery of a gene linked to leanness.

7 Jun 2016

Higher blood levels of methotrexate impair executive functioning in long-term pediatric ALL survivors

Research from St. Jude Children's Research Hospital suggests that pediatric leukemia patients exposed to higher concentrations of the chemotherapy drug methotrexate are more likely to struggle with mental flexibility, organization and related skills as long-term survivors.

7 Jun 2016

More effective absorption with a pioneering oral vitamin spray

What a difference a spray makes when it comes to effectively absorbing key nutrients, say health pioneers BetterYou following the BBC’s 'The Truth About Healthy Eating' programme which aired last week (2 June).

From BetterYou Ltd 7 Jun 2016

Alabama physician recommends childbearing-age women to take precautions against Zika virus

As concerns about the Zika virus rise among women of childbearing age in the United States, Joseph Biggio, M.D., director of the University of Alabama at Birmingham Division of Maternal-Fetal Medicine, wants those who are pregnant or trying to conceive to take precautions.

6 Jun 2016

Scientists use X-rays to study how eculizumab prevents immune system from damaging kidney tissue

In collaboration with Alexion Pharmaceuticals, Inc., scientists from Aarhus University have used X-rays to understand how the therapeutic antibody eculizumab prevents our immune system from destroying red blood cells and damaging kidney tissue.

6 Jun 2016

IQWiG examines whether ramucirumab drug offers added benefit for MCRC and NSCLC patients

Ramucirumab is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

6 Jun 2016

Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Empagliflozin has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.

6 Jun 2016

Rare DNA alteration may increase rsk of multiple sclerosis

Scientists at the University of British Columbia and Vancouver Coastal Health have proven that multiple sclerosis (MS) can be caused by a single genetic mutation - a rare alteration in DNA that makes it very likely a person will develop the more devastating form of the neurological disease.

6 Jun 2016

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

6 Jun 2016

Joint research reveals key mechanisms of persistent latent infection of HTLV-1

Joint research between scientists from Kumamoto University, Japan and Imperial College London, UK has revealed the mechanisms of persistent latent infection of the human T-cell leukemia virus type 1 (HTLV-1).

6 Jun 2016

Blood News and Research

Tanaka develops world's first kit to directly detect ZIKA virus in blood

Coagadex now available for rare bleeding disorder patients in the UK

Existing immunotherapy drug pembrolizumab shows promise for specific sarcoma subtypes

Study may help identify genetic basis of why some people's brains age better than others

Disruptive sleep patterns could raise heart disease risk in shift workers and insomniacs

Study establishes copper’s role in fat metabolism

Eculizumab drug provides new hope for kidney failure patients

Research shows weekend admissions in NHS hospital can affect AF patients

Human stem cells restore motor function in chronic stroke patients

Researchers establish new method to culture kidney progenitor cells for regenerative medicine

Genes of healthy leanness could lead to new approach to treating obesity-related diabetes

Higher blood levels of methotrexate impair executive functioning in long-term pediatric ALL survivors

More effective absorption with a pioneering oral vitamin spray

Alabama physician recommends childbearing-age women to take precautions against Zika virus

Scientists use X-rays to study how eculizumab prevents immune system from damaging kidney tissue

IQWiG examines whether ramucirumab drug offers added benefit for MCRC and NSCLC patients

Study finds no added benefit of empagliflozin alone or in combination for type 2 diabetes

Rare DNA alteration may increase rsk of multiple sclerosis

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Joint research reveals key mechanisms of persistent latent infection of HTLV-1

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News